German-based, vertically integrated cannabis company, Eurox, a SEED Innovations Limited portfolio company, has changed its name to Avextra.
German-based cannabis extracts manufacturer Avextra Eurox has rebranded to Avextra. The rebrand, the company says, emphasises its clear focus on the highest quality cannabis extracts and its commitment to the development of evidence-based cannabis medicines.
SEED Innovations Ltd is an AIM quoted company investing in fast-growing businesses with a focus on the medical cannabis, health and wellness space. It has a 8.85 per cent shareholding in Avextra.
Avextra provides SEED with direct access into Germany, the largest cannabis market in Europe today. The vertically integrated production capabilities of Avextra cover cultivation in its Portuguese facility, to manufacturing in Germany thanks to an exclusive, long-term manufacturing agreement in place with an EU GMP certified German pharmaceutical company.
The company began sales of its cannabis products in Germany in November 2021, and in June 2022, raised €4.4, in funding, with Portugal-based Iberis Capital becoming a new institutional investor – its first investment in medical cannabis.
Avextra (Eurox) emphasised at the time that the development underscored its commitment to its investment in Portugal as a botanical and pharmaceutical research and innovation centre in Europe.
Avextra will be exhibiting at the Expopharm Pharmacists Congress in Munich from 14-17 September 2022.